Logo image
Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography
Journal article   Open access   Peer reviewed

Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography

Elizabeth Greiner-Sosanko, Darla R Lower, Mohamed A Virji and Matthew D Krasowski
Biomedical chromatography, Vol.21(3), pp.225-228
03/2007
DOI: 10.1002/bmc.753
PMCID: PMC2231333
PMID: 17230449
url
https://www.ncbi.nlm.nih.gov/pmc/articles/2231333View
Open Access

Abstract

A high-performance liquid chromatography assay with ultraviolet detection was developed for the simultaneous determination of the anti-epileptic drugs lamotrigine, carbamazepine and zonisamide in human plasma and serum. Lamotrigine, carbamazepine, zonisamide and the internal standard chloramphenicol were extracted from serum or plasma using liquid-liquid extraction under alkaline conditions into an organic solvent. The method was linear in the range 1-30 microg/mL for lamotrigine, 2-20 microg/mL for carbamazepine, and 1-40 microg/mL for zonisamide. Within- and between-run precision studies demonstrated coefficient of variation <10% at all tested concentrations. Other anti-epileptic medications tested did not interfere with the assay. The method is appropriate for determining lamotrigine, carbamazepine and zonisamide serum or plasma concentrations for therapeutic monitoring.
Anticonvulsants - blood Reproducibility of Results Chromatography, High Pressure Liquid - methods Spectrophotometry, Ultraviolet - methods Humans Plasma - chemistry Sensitivity and Specificity Isoxazoles - blood Adult Triazines - blood Carbamazepine - blood

Details

Metrics

Logo image